MPTNYSEReal Estate Investment TrustsFiscal year ends December 31

MEDICAL PROPERTIES TRUST INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026

$2.85−0.16 (-5.32%)

Close on Oct 19, 2026

Market cap: $1.70B
P/E (TTM): –
Dividend yield: 11.23%

MEDICAL PROPERTIES TRUST INC income statement

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31
Revenue	972	996	872	1,543	1,545	1,249	854	785	705	541	442	313	243	198	132	108	114
Cost of Revenue	90	74	110	167	101	30	168	84	–	–	–	–	–	–	–	–	–
Gross Profit	882	921	762	1,375	1,443	1,219	686	700	–	–	–	–	–	–	–	–	–
General & Administrative	130	134	146	160	146	132	96	81	59	49	44	37	30	29	27	27	21
Total Costs & Expenses	943	1,027	1,202	898	873	750	511	447	396	352	179	170	89	68	62	66	46
Operating Income	–	–	–	–	–	–	–	–	486	342	263	143	154	130	70	42	68
Interest Expense	510	418	411	359	367	329	238	223	177	160	121	98	67	58	44	34	38
Interest & Investment Income	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.10	1.52	0.04
Income from Equity Investments	98	-367	14	41	28	20	16	14	10	–	–	–	–	–	–	–	–
Other Non-Operating Income	-267	-2,333	-357	315	60	-36	30	681	-15	30	-123	-92	-64	-57	-58	-39	-38
Asset Impairment Charges	–	–	–	–	–	19	21	48	–	7.23	–	50	–	–	0.56	12	–
Gain (Loss) on Investments	–	–	–	–	41	–	–	–	–	–	–	–	–	–	–	–	–
Pretax Income	-237	-2,364	-687	960	731	463	374	1,019	294	219	141	51	90	73	–	–	–
Income Tax Expense	39	44	-131	56	74	31	-2.62	0.93	2.68	-6.83	1.50	0.34	0.73	0.02	0.13	1.60	0.30
Income from Continuing Operations	–	–	–	–	–	–	–	–	291	226	140	51	89	73	12	3.03	30
Income from Discontinued Operations	–	–	–	–	–	–	–	–	–	0.00	–	0.00	7.91	17	15	20	6.42
Net Income incl. Noncontrolling Interests	-276	-2,408	-556	904	657	432	376	1,018	291	226	140	51	97	90	27	23	36
Minority Interest in Earnings	1.11	1.98	0.38	1.22	0.92	0.82	1.72	1.79	1.45	0.89	0.33	0.27	0.22	0.18	0.18	0.10	0.04
Net Income	-277	-2,410	-556	903	656	431	375	1,017	290	225	140	51	97	90	27	23	36
EPS (Basic)(per share)	-0.46	-4.02	-0.93	1.50	1.11	0.81	0.87	2.77	0.82	0.86	0.64	0.29	0.64	0.67	0.23	0.22	0.45
EPS (Diluted)(per share)	-0.46	-4.02	-0.93	1.50	1.11	0.81	0.87	2.76	0.82	0.86	0.63	0.29	0.63	0.67	0.23	0.22	0.45
Shares Outstanding (Basic, Weighted)(shares)	601	600	599	599	589	529	427	365	350	260	218	170	151	132	111	101	78
Shares Outstanding (Diluted, Weighted)(shares)	601	600	599	599	590	530	428	366	350	261	218	171	153	132	111	101	78
Dividend per Share(per share)	0.32	0.38	1.17	1.15	1.11	1.07	1.01	0.99	0.95	0.90	0.87	0.84	0.80	0.80	0.80	0.80	0.80
EBITDA	–	–	–	–	–	–	–	–	618	439	335	198	192	165	106	69	94
Provision for Credit Losses	168	1,241	10	99	42	3.26	–	–	–	–	–	–	–	–	1.50	2.40	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 86.5%
Operating margin: –
Net margin: -3.0%
Return on equity, FY2025: -5.9%

Financial strength

Current ratio: –
Debt to equity: –
Debt to assets: –
Cash to current liabilities: –

Valuation

P/E ratio: –
Price to sales: 1.67
Price to book: 0.38
Dividend yield: 11.23%